Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still no news looks like they letting this go up so they can short it again. Which I think is a good thing because it means they have found a bottom at the low of today !!!!
So I’ll be buying again next week at today’s lows :)
I will never recover what I have lost in this company over the years :(
Ok I’ve changed my mind/ gamble time. Sell me some shares!!!!!! :)
I certainly agree but see they have some new management so we’ll see ?
If they ever get funding this stock will blast off !!!!
Since we didn’t get news in January February I can only assume that they are still working on funding. I’m still holding long but can’t add atm. :)
Ok that’s a Vedic from last year construction was stopped for funding issues. We know this which is why we are waiting on news :)
What’s the publish date on that video???
I’m adding shares everyday :)))
Much of that charts opinion come from the last few weeks with the price falling and the dilution. Moving forward let’s see what they can do. They do have other drugs
I hope they can come up with some financing lol
https://www.barchart.com/stocks/quotes/ONCX/opinion
That tweet sounded a little anger to me lol
Any news would be helpful lol
Good morning millionaires:))))
Don’t think we getting news in February :( no reply to my email either
<————all shares locked !!!!!
And they are still selling shares :((((((
Unfortunately I think your right oh well it wouldn’t be the first penny stock I rode to zerooooooo lol
Need something current and quickly
That’s from 2016 . Come on??
Re: tutankhamuns Post# 41569
EMA vs VYST**The Facts per Greg Rotman...
I spoke to Greg Rotman yesterday. I had reached out to him over a week ago and I had not received a call back until yesterday. He told me that he was very busy dealing with the very frivolous legal issue that EMA filed against them. He told me the EMA is 100% wrong and at fault and that such will be proven.
VYST had to change their Transfer Agent (TA) to stop what EMA was erroneously and illegally doing. EMA was going through the old VYST TA to convert the debt on the pre-paid interest. The problem was that the interest was already pre-paid by VYST so there were no conversions that should have ever been "legally" allowed to be executed. They did this not once, not twice, but numerous times to the tune of illegally converting over 50+ million shares.
Then they sent an email to VYST indicating that they made an error and sent an amended "Notice of Conversion" trying to fix the situation after the fact. This is why VYST had to transfer to a different Transfer Agent (TA) because EMA had shown no evidence of slowing down with illegally converting shares.
I asked Greg if I can post this conversation and if he had any facts that he could provide to prove what I am going to post and he said sure. He said that he will send me what he will send any other shareholder or any shareholder that wants to see the VYST corporate documents in person.
Look at the first "Notice of Conversion" date then look at the second "Notice of Conversion" date trying to fix their error then look at the email from EMA confirming that they were the ones who made the error...
Quote:
v/r
Sterling
Replies:
wow...finally a post worth reading. I almost gave
StocksGoneWild on 2/25/2019 12:13:22 PM
Doesn’t that mean that the note was only
tutankhamuns on 2/25/2019 12:18:29 PM
VYST had to change their Transfer Agent (TA)
doogdilinger on 2/25/2019 12:19:50 PM
Vindication. Thank you Sir. VYST
HMB2010 on 2/25/2019 12:21:23 PM
THANK YOU Sterling!!! That is the most amazing
doogdilinger on 2/25/2019 12:24:38 PM
This is a must read EMA illegally converted
cjstocksup on 2/25/2019 12:26:23 PM
Thank you so very much for your proof
Bionic Man on 2/25/2019 12:29:43 PM
Thanks ever so much, Sterling!
reader3 on 2/25/2019 12:31:39 PM
EMA sneaky bastages
Scotttrader80 on 2/25/2019 12:33:15 PM
"CLERICAL ERROR" : We all know what it
ArryHere on 2/25/2019 12:36:09 PM
Thank you stervc. Game changing info.
46er on 2/25/2019 12:37:39 PM
MODS PLEASE STICKIE THIS!
Bionic Man on 2/25/2019 12:43:31 PM
EMA needs to buy back 50M shares, LMAO!
War Shark on 2/25/2019 12:43:37 PM
Dang. What dirty bastards. I’d sticky this
Venture_Cap on 2/25/2019 12:44:30 PM
Sterling you have just been elected Captain for
glenngroove on 2/25/2019 12:44:41 PM
Must read by StervC- VYST Long n Strong
RavenDusk1 on 2/25/2019 1:12:56 PM
Thanks Stervc for the report on EMA illegal activity.
hondobud on 2/25/2019 2:49:03 PM
EMA is going to be begging for mercy soon!!!
Bull$hark on 2/25/2019 3:19:30 PM
Thank You once again Sterling! Another Top
Ketobaker on 2/25/2019 9:11:35 PM
That is great news! Thanks so much for
TipsyOnWhiskey on 2/26/2019 7:24:45 AM
MODS STICKY PLEASE!
TipsyOnWhiskey on 2/26/2019 7:25:16 AM
Report TOS
I kinda hope it trades sideways so I can buy more in Friday :))))
OMG down 3.89 percent!!!!! Panic panic panic. Come on people relax lol.
As with any penny stock it’s a gamble! It’s pretty simple the company has a good idea and good technology however they need funding . There is a plant in Ohio that construction has started according to last quarter. It has stopped due to no financing. They get financing and we ride this up!! No financing and I think triple digits coming
Lol well the good news is it can’t go down much further lol
Happy Monday millionaire family !!
Rule 1 to learn
Don’t invest on what you read on messages boards unless it factually data from or about the company :)))
I don’t see any ten dollar mattresses here? Lol you must be in the ally in the back lol
https://www.rotmans.com/
At McDonald’s lol
Did Jam leave us again lololol
Nice looks like it’s about to break out
When quarterly report comes out this will skyrocket!!!!!!!! Patience and Cuban cigars friends lol :))))
Does anyone really buy or sell based on what is said in this room lololololol:))))))))
VYST !!!!!!! No matter what you can’t hold a good company down!!!!!!!!!!!!!
Picked up another 50k
I’m guessing will close today .08
They are here in any red day but go away in Green Day’s lol
I hope it does get to 3/4 I’m buying
This lawsuit is funny stuff lol
It’s like a fly on a rinos ass lol
I own a ton of shares in this company and would like to see it succeed but facts are facts
Read other event in this filing from January 2019
Current Report Filing (8-k)
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 29, 2018
Oncolix, Inc.
(Exact name of registrant as specified in its charter)
Florida
333-192405
46-3046340
(state or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification Number)
14405 Walters Road, Suite 780
Houston, TX
77014
(address of principal executive offices)
(zip code)
281-402-3167
(registrant’s telephone number, including area code)
_____________________________________________
(former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement
The disclosure set forth in Item 2.04 is incorporated herein by reference.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
The disclosure set forth in Item 2.04 is incorporated herein by reference.
Item 2.04 Triggering Events that Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Oncolix, Inc., a Florida corporation (“Company”), has outstanding convertible notes in the principal amount of $5,407,757. The Convertible Notes bear interest at a rate of 10% per annum, with accrued interest payable commencing April 1, 2019, then on the first day of each calendar month thereafter until maturity. The maturity of the Convertible Notes is August 1, 2019, but commencing on April 1, 2019 and on the first day of each calendar month thereafter until maturity, the Company is required to redeem an amount of the Convertible Notes equal to 1/5th of the original principal amount, plus 10% of such monthly redemption amount as a bonus.
On November 29, 2018, the Company entered into a variable rate, convertible debt financing in the amount of $83,000. This financing constituted an event of default under the terms of the Convertible Notes. At the holders’ option, the principal amount, accrued interest, and other amounts owing, shall immediately become due and payable. The holders have other rights (as a result of this event of default and the variable rate, convertible debt financing) as set forth in the securities purchase agreement and Convertible Notes that have been filed as exhibits to Forms 8-k filed with the SEC on August 9, 2017 and June 6, 2018.
Item 8.01 Other Events
The Company is halting enrollment in its Phase I clinical trial of Prolanta for the treatment of ovarian cancer as a result of injection site reactions at the current dose level. No other adverse effects or signs of toxicity have been observed for the drug.
Two subjects enrolled in the second dosing group, 1 mg per kg of body weight, have experienced inflammation and edema at the injection sites that resulted in their withdrawal from the study. Prolanta is injected subcutaneously daily during the treatment period. The Company believes that a reformulation or alternative dosing method of the drug will be required to continue the clinical evaluation of the drug, and such changes may require additional preclinical toxicity studies and additional clearance by the U.S. Food and Drug Administration. The Company does not have the financial resources at this time to conduct such additional studies.
The Company will evaluate its development plans, including accelerating its development timelines for CycloSam, its other product candidate.
Item 9.01 Financial Statements and Exhibits
(b) Exhibits.
10.1
Securities Purchase Agreement by and between the Company and Power-Up Lending Group, Ltd., dated 11/27/2018
10.2
Convertible Promissory Note by and between the Company and Power-Up Lending Group, Ltd., dated 11/27/2018
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Oncolix, Inc.
Dated: January 2, 2019
By:
/s/ Michael T. Redman
Michael T. Redman
Chief Executive Officer
3